← Back to Search

Behavioral Intervention

Digital Health Tool for Improving Medication Adherence in Diabetes

N/A
Waitlist Available
Led By Jacqueline Seiglie
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Take at least one diabetes medication
Type 2 diabetes mellitus
Timeline
Screening 3 weeks
Treatment Varies
Follow Up collected at 0, 3, and 6 months
Awards & highlights

Study Summary

This trial will test a text message-based tool to help Latino adults with diabetes better manage their medication, reducing diabetes-related complications in the fastest growing US ethnic group.

Who is the study for?
This trial is for Latino adults with type 2 diabetes who prefer to speak and read Spanish, have had suboptimal medication adherence, and an HbA1c level of ≥8.0% since 2018. Participants must be over 18, use a mobile phone with texting, and receive care at MGH-affiliated practices. Those with hearing issues or unable to handle text messages are excluded.Check my eligibility
What is being tested?
The study tests REACH-Es, a digital health tool delivering tailored interactive text messages designed to help Latino adults overcome barriers to taking their diabetes medications consistently.See study design
What are the potential side effects?
Since the intervention involves only receiving and interacting with text messages aimed at improving medication adherence, there are no direct medical side effects associated with this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently taking medication for diabetes.
Select...
I have type 2 diabetes.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~collected at 0 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and collected at 0 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability
Diabetes Medication adherence
Feasibility (recruitment rate)
+4 more
Secondary outcome measures
Diabetes self-efficacy
HbA1c

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: REACH-EsExperimental Treatment1 Intervention
Participants in the REACH-Es arm will receive REACH-Es short message service (SMS), as follows: 1) Daily SMS (information related to diet, exercise, self-monitoring of blood glucose, their specific diabetes medication(s), and top 4 medication adherence barriers); 2) Daily two-way SMS (diabetes medication adherence question); 3) Weekly one-way SMS (participants receive weekly feedback on Sunday regarding how many of the last 7 days they took their medicine); 4) A SMS each time an HbA1c is collected with a link to a secure website that displays the result.
Group II: Enhanced treatment as usual (ETAU)Active Control1 Intervention
Participants will maintain care as usual (medication treatment and physician monitoring) in addition to a welcome SMS following enrollment, a SMS each time an HbA1c is collected with a link to a secure website that displays the result, and bi-monthly information on diabetes self-care education.

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,360 Previous Clinical Trials
4,314,782 Total Patients Enrolled
Massachusetts General HospitalLead Sponsor
2,936 Previous Clinical Trials
13,198,653 Total Patients Enrolled
Jacqueline SeigliePrincipal InvestigatorMassachusetts General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings to participate in this research initiative?

"The information on clinicaltrials.gov reveals that this specific trial is not currently recruiting participants, as it was last edited on August 15th 2023 and no longer available for enrollment. Although, there are a multitude of other trials actively searching for volunteers at the moment - 1449 to be exact."

Answered by AI

Who else is applying?

What site did they apply to?
Massachusetts General Hospital Diabetes Research Center
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults
Jacqueline A. Seiglie, MD 2024. "REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06000813.
~47 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top